About us

The regulation of gene expression, which includes epigenetic mechanisms, is a growing research area for industrial and academic interests in discovering novel drug targets.

Epigeneron was founded by Hodaka Fujii, MD, PhD and Toshitsugu Fujita, PhD to translate their innovative inventions, locus-specific ChIP and ORNi-PCR, into the industrial applications such as exploitation and identification of revolutionary drug targets and detection of rare gene sequences in biological specimens.

It pioneers revolutionary drug discovery based on epigenetic and other mechanisms of gene expression regulation with its proprietary technologies and accumulated knowledge.

Epigeneron is actively promoting business partnerships with companies in the pharmaceutical, diagnostic and other industrial areas enabling them to achieve extensive innovation in drug discovery, diagnostics and other molecular testing.

Access
Headquarter

Life Science Bldg. 8F, 1-9-10 Nihonbashihoridomecho, Chuo-ku, Tokyo 103-0012, Japan

Research Laboratory

CoLaborator Kobe
Kobe International Business Center (KIBC)
5-5-2 Minatojima Minamimachi, Chuo-ku, Kobe 650-0047, Japan